parallax background

Transforming and innovating the
Medicinal Cannabis industry to
generate substantial and positive
changes to the patients' lives.

Transforming and innovating the Medicinal Cannabis industry to generate substantial and positive changes to the patients' lives.

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

ABOUT PIAUHY

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

ABOUT PIAUHY

RESEARCH | R&D

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.


 
alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer
 
KNOW MORE

RESEARCH | R&D

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.


3

CANNABIS APPLICATIONS

alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer
KNOW MORE

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

NEWS

NEWS

July 1, 2022
July 1, 2022
Categories

Closing discussion | The Future of Neurosciences and Mental Disorders | Agorà Conference 2022

Laura Ramos, journalist of Canna Reporter, mediated our roundtable discussion. Our speakers had the time to explore deeply Laura’s questions and dedicate an open space to […]
Do you like it?
Read more
June 24, 2022
June 24, 2022
Categories

Frontiers of Neuroscience and Mental Health in the 21st Century | Sidarta Ribeiro | Agorà Conference 2022

Are psychedelics the future treatment for mental disorders?  Prof. Sidarta Ribeiro shared with us a new vision of the use of psychedelics in medicine. Schizophrenia, depression, […]
Do you like it?
Read more
June 17, 2022
June 17, 2022
Categories

The Neurobiology of Medical Cannabis treatment in Autism | Renato Malcher | Agorà Conference 2022

Prof. Renato Malcher presented some studies where cannabinoids have been used as an alternative therapy for children with Autism and to reduce Epileptic seizures.Recap the talk […]
Do you like it?
Read more

OUR ECOSYSTEM

OUR ECOSYSTEM

 
1.jpg
logo_UA
UAi_halternativa_designacao_1555075011702
 
 

JOIN OUR NEWSLETTER

Terms and Conditions